Baillie Gifford trim Beam Therapeutics Inc.
Baillie Gifford trim $8.8M of disclosed value in Beam Therapeutics Inc..
Signal
Investor Move
Action
Trim
Capital
$8.8M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.